Integra Lifesciences Holdings Corp

Research Integra Lifesciences Holdings Corp (IART) on Bullrun: market cap USD 1.46B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIART
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 1.46B
• Financial periodFY2025
• RevenueUSD 1.64B
• Revenue growth1.5%
• Net income-USD 516.80M
• Free cash flow-USD 31.05M
• Gross margin50.9%

Valuation Snapshot

latest market cap is USD 1.46B.

About Integra Lifesciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.

Frequently asked questions

What is Integra Lifesciences Holdings Corp's market cap?

Integra Lifesciences Holdings Corp's market capitalization is USD 1.46B.

What does Integra Lifesciences Holdings Corp do?

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.